TickerFacts.

Can-Fite BioPharma Ltd. (CANF): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

1.65M
Year ended 2025-12-31
-87.4%
3-year compound annual growth
815.75M2020-12-31: 358.41M2021-12-31: 553.08M2022-12-31: 815.75M2023-12-31: 426.1K2024-12-31: 725.3K2025-12-31: 1.65M1.65M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-311.65M+127.0%2026-03-26, From 2025-01-01
2024-12-31725.3K+70.2%2026-03-26, From 2024-01-01
2023-12-31426.1K-99.9%2026-03-26, From 2023-01-01
2022-12-31815.75Mn/c2025-04-14, From 2022-01-01
2021-12-31553.08Mn/c2024-03-28, From 2021-01-01
2020-12-31358.41Mn/a2023-03-30, From 2020-01-01